Liptor EZ Tablet 10 mg + 10 mg is a combination oral medication containing Atorvastatin Calcium (10 mg) and Ezetimibe (10 mg), designed to manage high cholesterol and mixed dyslipidemia effectively. This dual therapy combines two complementary mechanisms to target elevated low-density lipoprotein (LDL) cholesterol, total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein (HDL) cholesterol.

Atorvastatin, a statin, inhibits HMG-CoA reductase, the key enzyme responsible for cholesterol synthesis in the liver, leading to reduced LDL and total cholesterol levels. Ezetimibe, on the other hand, selectively blocks the intestinal absorption of cholesterol and related phytosterols. By combining these two agents, Liptor EZ achieves enhanced lipid-lowering effects compared to either component alone.

This combination is particularly beneficial for patients who are at high risk of cardiovascular disease, including those with atherosclerosis, diabetes, or a history of heart attacks, and for patients who do not reach target lipid levels with statin monotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

HMG-CoA Reductase Inhibitor (Statin) + Cholesterol Absorption Inhibitor

Indications

Liptor EZ Tablet 10 mg + 10 mg is indicated for:

• Primary hypercholesterolemia (Type IIa) and mixed dyslipidemia (Type IIb)

• Familial hypercholesterolemia (heterozygous) as an adjunct to diet and lifestyle changes

• Patients inadequately controlled on statin therapy alone

• Reduction of LDL cholesterol in adults at high cardiovascular risk

• Atherosclerotic cardiovascular disease prevention, including myocardial infarction and stroke risk reduction

The medication should be used in combination with a cholesterol-lowering diet, exercise, and other lifestyle interventions for optimal outcomes.

Pharmacology

Atorvastatin:

• Inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver

• Lowers plasma LDL cholesterol and total cholesterol

• Reduces triglycerides and modestly increases HDL cholesterol

• Stabilizes atherosclerotic plaques and provides anti-inflammatory benefits

Ezetimibe:

• Selectively inhibits intestinal absorption of cholesterol at the brush border of the small intestine

• Reduces cholesterol delivery to the liver, promoting LDL receptor upregulation

• Complements the action of statins for greater LDL reduction

Combination Effect:

• Greater reduction in LDL cholesterol than either drug alone

• Reduces total cholesterol, Apo B, and triglycerides

• Improves cardiovascular risk profile while maintaining safety

Dosage and Administration

• Adults: 1 tablet once daily, with or without food

• Usually combined with a low-cholesterol diet

• Dose may be adjusted according to lipid profile and therapeutic response

• Periodic monitoring of lipid levels and liver function is recommended

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Monitor liver function tests periodically

• Use caution in patients with active liver disease or unexplained persistent elevations of liver enzymes

• Report muscle pain, tenderness, or weakness, which may indicate myopathy or rhabdomyolysis

• Avoid concurrent use with certain drugs that increase the risk of statin-induced myopathy

Possible Side Effects

• Common: headache, abdominal pain, dyspepsia, nausea

• Musculoskeletal: myalgia, mild muscle weakness

• Rare: myopathy, rhabdomyolysis

• Liver enzyme elevation may occur; periodic monitoring advised

Contraindications

• Hypersensitivity to atorvastatin, ezetimibe, or any component of the formulation

• Active liver disease or unexplained persistent liver enzyme elevation

• Pregnancy and breastfeeding

• Concomitant use with strong CYP3A4 inhibitors or drugs that increase myopathy risk

Pregnancy & Lactation

• Pregnancy Category X: contraindicated due to potential fetal harm

• Not recommended during breastfeeding

Storage

Store in a cool, dry place below 30°C, away from light and moisture. Keep out of reach of children.